Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Marra

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agentsPaolo Tarantino, Antonio Marra, Sara Gandini, et al.
Expert Opinion on Pharmacotherapy|June 5, 2020
Pharmacological management of male breast cancerBruno A Duso, Dario Trapani, Antonio Marra, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2022
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomasDara S Ross, Kelly A Devereaux, Cao Jin, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
NPJ Breast Cancer|December 16, 2025
Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI modelsChiara Frascarelli, Konstantinos Venetis, Antonio Marra, et al.
Expert Opinion on Pharmacotherapy|May 22, 2026
Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title: oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancerJulian David Etessami, Carmine Valenza, Pier Paolo Maria Berton Giachetti, et al.
Arquivos Brasileiros De Cardiologia|January 31, 2007
Determination of mitral valve area through pressure half-time measurements in the left atrium and pulmonary capillary wedgeEvandro Cesar Vidal Osterne, Jorge Haddad, Vicente Paulo da Motta, et al.
JNCI Cancer Spectrum|December 21, 2020
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical TrialsFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Cancer Treatment Reviews|May 21, 2024
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast CancerLuca Boscolo Bielo, Dario Trapani, Eleonora Nicolò, et al.
Vaccines|February 26, 2026
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future DirectionsJorge Iranzo, Edoardo Giordano, Renato Maria Marsicano, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agentsPaolo Tarantino, Antonio Marra, Sara Gandini, et al.
Expert Opinion on Pharmacotherapy|June 5, 2020
Pharmacological management of male breast cancerBruno A Duso, Dario Trapani, Antonio Marra, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2022
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomasDara S Ross, Kelly A Devereaux, Cao Jin, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
NPJ Breast Cancer|December 16, 2025
Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI modelsChiara Frascarelli, Konstantinos Venetis, Antonio Marra, et al.
Expert Opinion on Pharmacotherapy|May 22, 2026
Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title: oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancerJulian David Etessami, Carmine Valenza, Pier Paolo Maria Berton Giachetti, et al.
Arquivos Brasileiros De Cardiologia|January 31, 2007
Determination of mitral valve area through pressure half-time measurements in the left atrium and pulmonary capillary wedgeEvandro Cesar Vidal Osterne, Jorge Haddad, Vicente Paulo da Motta, et al.
JNCI Cancer Spectrum|December 21, 2020
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical TrialsFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Cancer Treatment Reviews|May 21, 2024
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast CancerLuca Boscolo Bielo, Dario Trapani, Eleonora Nicolò, et al.
Vaccines|February 26, 2026
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future DirectionsJorge Iranzo, Edoardo Giordano, Renato Maria Marsicano, et al.
Pageof 11